Goldstein J, Mostowsky H, Tung J, Hon H, Brunswick M, Kozlowski S
Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Eur J Immunol. 1997 Apr;27(4):871-8. doi: 10.1002/eji.1830270411.
In this report, we demonstrate stimulation of T cell receptor (TCR) transgenic CD8 T cells by isolated major histocompatibility complex (MHC) class I H-2Ld complexes and antigenic peptide. This is the first demonstration of CD8 T cells activated by MHC and antigenic peptide in the absence of antigen priming. Furthermore, isolated MHC and a potent peptide antigen can stimulate phenotypically naive CD44- T cells to become CTL effectors and to produce interleukin-2 in nanogram per milliliter amounts. These results demonstrate that particular TCR antigen pairs may overcome the need for specialized antigen-presenting cells and have implications for mechanisms of autoimmunity and tolerance induction.
在本报告中,我们展示了分离出的主要组织相容性复合体(MHC)I类H-2Ld复合体和抗原肽对T细胞受体(TCR)转基因CD8 T细胞的刺激作用。这是首次证明在没有抗原致敏的情况下,MHC和抗原肽可激活CD8 T细胞。此外,分离出的MHC和一种有效的肽抗原可刺激表型上未成熟的CD44-T细胞成为细胞毒性T淋巴细胞(CTL)效应细胞,并产生纳克每毫升量的白细胞介素-2。这些结果表明,特定的TCR-抗原对可能无需专门的抗原呈递细胞,并对自身免疫和耐受性诱导机制具有重要意义。